Language selection

Search


Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age.HP5-139/1-2022E-PDF ; HP5-139/2-2022E-PDF

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.913119&sl=0

Publication information
Department/Agency
  • Public Health Agency of Canada, issuing body.
TitleRecommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age.
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Recommandations sur l'utilisation du vaccin Spikevax de Moderna contre la COVID-19 chez les enfants de 6 mois à 5 ans.
  • At head of title: An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI).
  • Issued also in HTML format.
  • Includes bibliographical references (pages 25-27).
Publishing information
  • Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, July 14, 2022.
  • ©2022
Description1 online resource (27 pages) + summary (6 pages)
ISBN9780660444543 9780660444550
Catalogue number
  • HP5-139/1-2022E-PDF
  • HP5-139/2-2022E-PDF
Departmental catalogue number220315 (main report) 220313 (summary)
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details